D-0552-2026 Class III Ongoing
FDA drug recall D-0552-2026 was initiated by Eugia US LLC on May 18, 2026 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan The recall status is ongoing. Affected quantity: 168,300 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- June 10, 2026
- Initiation Date
- May 18, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 168,300 vials
Product Description
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Reason for Recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Distribution Pattern
US Nationwide.
Code Information
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029